Skip to main content
Top
Published in: International Urology and Nephrology 9/2018

01-09-2018 | Nephrology - Original Paper

Impact of hemoglobin variability on cardiovascular mortality in maintenance hemodialysis patients

Authors: Fu-Jun Lin, Xi Zhang, Lu-Sheng Huang, Gang Ji, Hai-Dong Huang, Yun Xie, Geng-Ru Jiang, Xin Zhou, Wei Lu

Published in: International Urology and Nephrology | Issue 9/2018

Login to get access

Abstract

Purpose

Although the association between anemia and cardiovascular mortality in hemodialysis patients is well established, whether hemoglobin variability (Hgb-Var) affects the prognosis remains unclear. We aimed to evaluate the association between Hgb-Var and cardiovascular mortality in Chinese hemodialysis patients.

Methods

This retrospective study included 252 patients starting hemodialysis in Xin Hua Hospital between January 2009 and December 2015. Patients were divided into three tertiles based on Hgb-Var, as reflected by SD Hgbmean, SD Hgbrange, and Hgbdeflection during a 12-month evaluation period after hemodialysis initiation. Left ventricular ejection fraction (EF) and left ventricular mass index (LVMI) were evaluated by echocardiography. Information on cardiovascular deaths occurred by December 2017 was collected. Multivariate Cox regression models were constructed to evaluate the association between Hgb-Var and cardiovascular mortality.

Results

A total of 75 deaths and 52 cardiovascular deaths occurred during the 47-month follow-up (range 29.5–70). Under multivariate regression, the subgroup with the highest Hgb-Var had a higher risk of cardiovascular mortality after adjusting for relevant factors (HR vs. lowest SD Hgbmean: 9.15, 95% CI 2.82, 29.693, P < 0.0001; HR vs. lowest SD Hgbrange: 3.81, 95% CI 1.40, 10.38, P = 0.005). Per 1 SD of Hgbmean and Hgbrange elevations were both related to a 10% increase in the cardiovascular mortality risk. Baseline EF% and LVMI did not differ across the Hgb-Var subgroups. EF% upon the last patient visit to the clinic was lower in the subgroup with the highest SD Hgbmean (P = 0.02).

Conclusions

High Hgb-Var is an independent risk factor for cardiovascular mortality in hemodialysis patients and might influence the cardiac function.
Literature
1.
go back to reference Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE (1996) The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 28:53–61CrossRefPubMed Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE (1996) The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 28:53–61CrossRefPubMed
2.
go back to reference Eckardt KU (2005) Managing a fateful alliance: anaemia and cardiovascular outcomes. Nephrol Dial Transplant 20(Suppl 6):vi16–20CrossRefPubMed Eckardt KU (2005) Managing a fateful alliance: anaemia and cardiovascular outcomes. Nephrol Dial Transplant 20(Suppl 6):vi16–20CrossRefPubMed
3.
go back to reference Ebben JP, Gilbertson DT, Foley RN, Collins AJ (2006) Hemoglobin level variability: associations with comorbidity, intercurrent events, and hospitalizations. Clin J Am Soc Nephrol 1:1205–1210CrossRefPubMed Ebben JP, Gilbertson DT, Foley RN, Collins AJ (2006) Hemoglobin level variability: associations with comorbidity, intercurrent events, and hospitalizations. Clin J Am Soc Nephrol 1:1205–1210CrossRefPubMed
4.
go back to reference Eckardt KU, Scherhag A, Macdougall IC, Tsakiris D, Clyne N, Locatelli F, Zaug MF, Burger HU, Drueke TB (2009) Left Ventricular Geometry Predicts Cardiovascular Outcomes Associated with Anemia Correction in CKD. J Am Soc Nephrol 20:2651–2660CrossRefPubMedPubMedCentral Eckardt KU, Scherhag A, Macdougall IC, Tsakiris D, Clyne N, Locatelli F, Zaug MF, Burger HU, Drueke TB (2009) Left Ventricular Geometry Predicts Cardiovascular Outcomes Associated with Anemia Correction in CKD. J Am Soc Nephrol 20:2651–2660CrossRefPubMedPubMedCentral
5.
go back to reference Parfrey PS, Lauve M, Latremouille-Viau D, Lefebvre P (2009) Erythropoietin therapy and left ventricular mass index in CKD and ESRD patients: a meta-analysis. Clin J Am Soc Nephrol 4:755–762CrossRefPubMedPubMedCentral Parfrey PS, Lauve M, Latremouille-Viau D, Lefebvre P (2009) Erythropoietin therapy and left ventricular mass index in CKD and ESRD patients: a meta-analysis. Clin J Am Soc Nephrol 4:755–762CrossRefPubMedPubMedCentral
6.
go back to reference Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging 16:233–271CrossRefPubMed Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging 16:233–271CrossRefPubMed
7.
go back to reference Yang W, Israni RK, Brunelli SM, Joffe MM, Fishbane S, Feldman HI (2007) Hemoglobin variability and mortality in ESRD. J Am Soc Nephrol 18:3164–3170CrossRefPubMed Yang W, Israni RK, Brunelli SM, Joffe MM, Fishbane S, Feldman HI (2007) Hemoglobin variability and mortality in ESRD. J Am Soc Nephrol 18:3164–3170CrossRefPubMed
8.
go back to reference Members AF, Mancia G, De Backer G et al (2006) 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 28:1462–1536CrossRef Members AF, Mancia G, De Backer G et al (2006) 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 28:1462–1536CrossRef
9.
go back to reference McCullough PA, Chan CT, Weinhandl ED, Burkart JM, Bakris GL (2016) Intensive hemodialysis, left ventricular hypertrophy, and cardiovascular disease. Am J Kidney Dis 68:S5–S14CrossRefPubMed McCullough PA, Chan CT, Weinhandl ED, Burkart JM, Bakris GL (2016) Intensive hemodialysis, left ventricular hypertrophy, and cardiovascular disease. Am J Kidney Dis 68:S5–S14CrossRefPubMed
10.
go back to reference Weinhandl ED, Peng Y, Gilbertson DT, Bradbury BD, Collins AJ (2011) Hemoglobin variability and mortality: confounding by disease severity. Am J Kidney Dis 57:255–265CrossRefPubMed Weinhandl ED, Peng Y, Gilbertson DT, Bradbury BD, Collins AJ (2011) Hemoglobin variability and mortality: confounding by disease severity. Am J Kidney Dis 57:255–265CrossRefPubMed
11.
go back to reference Lau JH, Gangji AS, Rabbat CG, Brimble KS (2010) Impact of haemoglobin and erythropoietin dose changes on mortality: a secondary analysis of results from a randomized anaemia management trial. Nephrol Dial Transplant 25:4002–4009CrossRefPubMed Lau JH, Gangji AS, Rabbat CG, Brimble KS (2010) Impact of haemoglobin and erythropoietin dose changes on mortality: a secondary analysis of results from a randomized anaemia management trial. Nephrol Dial Transplant 25:4002–4009CrossRefPubMed
12.
go back to reference Altunoren O, Dogan E, Sayarlioglu H, Acar G, Yavuz YC, Aydın N, Sahin M, Akkoyun M, Isik IO, Altunoren O (2013) Effect of hemoglobin variability on mortality and some cardiovascular parameters in hemodialysis patients. Ren Fail 35:819–824CrossRefPubMed Altunoren O, Dogan E, Sayarlioglu H, Acar G, Yavuz YC, Aydın N, Sahin M, Akkoyun M, Isik IO, Altunoren O (2013) Effect of hemoglobin variability on mortality and some cardiovascular parameters in hemodialysis patients. Ren Fail 35:819–824CrossRefPubMed
13.
go back to reference Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450–458CrossRefPubMed Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450–458CrossRefPubMed
14.
go back to reference Boudville NC, Djurdjev O, Macdougall IC, de Francisco AL, Deray G, Besarab A, Stevens PE, Walker RG, Ureña P, Iñigo P, Minutolo R, Haviv YS, Yeates K, Agüera ML, MacRae JM, Levin A (2009) Hemoglobin variability in nondialysis chronic kidney disease: examining the association with mortality. Clin J Am Soc Nephrol 4:1176–1182CrossRefPubMedPubMedCentral Boudville NC, Djurdjev O, Macdougall IC, de Francisco AL, Deray G, Besarab A, Stevens PE, Walker RG, Ureña P, Iñigo P, Minutolo R, Haviv YS, Yeates K, Agüera ML, MacRae JM, Levin A (2009) Hemoglobin variability in nondialysis chronic kidney disease: examining the association with mortality. Clin J Am Soc Nephrol 4:1176–1182CrossRefPubMedPubMedCentral
15.
go back to reference Brunelli SM, Joffe MM, Israni RK, Yang W, Fishbane S, Berns JS, Feldman HI (2008) History-adjusted marginal structural analysis of the association between hemoglobin variability and mortality among chronic hemodialysis patients. Clin J Am Soc Nephrol 3:777–782CrossRefPubMedPubMedCentral Brunelli SM, Joffe MM, Israni RK, Yang W, Fishbane S, Berns JS, Feldman HI (2008) History-adjusted marginal structural analysis of the association between hemoglobin variability and mortality among chronic hemodialysis patients. Clin J Am Soc Nephrol 3:777–782CrossRefPubMedPubMedCentral
16.
go back to reference Gilbertson DT, Ebben JP, Foley RN, Weinhandl ED, Bradbury BD, Collins AJ (2008) Hemoglobin level variability: associations with mortality. Clin J Am Soc Nephrol 3:133–138CrossRefPubMedPubMedCentral Gilbertson DT, Ebben JP, Foley RN, Weinhandl ED, Bradbury BD, Collins AJ (2008) Hemoglobin level variability: associations with mortality. Clin J Am Soc Nephrol 3:133–138CrossRefPubMedPubMedCentral
17.
go back to reference Eckardt KU, Kim J, Kronenberg F, Aljama P, Anker SD, Canaud B, Molemans B, Stenvinkel P, Schernthaner G, Ireland E, Fouqueray B, Macdougall IC (2010) Hemoglobin variability does not predict mortality in European hemodialysis patients. J Am Soc Nephrol 21:1765–1775CrossRefPubMedPubMedCentral Eckardt KU, Kim J, Kronenberg F, Aljama P, Anker SD, Canaud B, Molemans B, Stenvinkel P, Schernthaner G, Ireland E, Fouqueray B, Macdougall IC (2010) Hemoglobin variability does not predict mortality in European hemodialysis patients. J Am Soc Nephrol 21:1765–1775CrossRefPubMedPubMedCentral
18.
go back to reference Fishbane S, Berns JS (2005) Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin. Kidney Int 68:1337–1343CrossRefPubMed Fishbane S, Berns JS (2005) Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin. Kidney Int 68:1337–1343CrossRefPubMed
19.
go back to reference Kalantar-Zadeh K, Aronoff GR (2009) Hemoglobin variability in anemia of chronic kidney disease. J Am Soc Nephrol 20:479–487CrossRefPubMed Kalantar-Zadeh K, Aronoff GR (2009) Hemoglobin variability in anemia of chronic kidney disease. J Am Soc Nephrol 20:479–487CrossRefPubMed
20.
go back to reference Singh AK (2010) The FDA’s perspective on the risk for rapid rise in hemoglobin in treating CKD anemia: Quo vadis. Clin J Am Soc Nephrol 5:553–556CrossRefPubMed Singh AK (2010) The FDA’s perspective on the risk for rapid rise in hemoglobin in treating CKD anemia: Quo vadis. Clin J Am Soc Nephrol 5:553–556CrossRefPubMed
21.
go back to reference Noordzij M, Jager KJ (2014) Increased mortality early after dialysis initiation: a universal phenomenon. Kidney Int 85:12–14CrossRefPubMed Noordzij M, Jager KJ (2014) Increased mortality early after dialysis initiation: a universal phenomenon. Kidney Int 85:12–14CrossRefPubMed
Metadata
Title
Impact of hemoglobin variability on cardiovascular mortality in maintenance hemodialysis patients
Authors
Fu-Jun Lin
Xi Zhang
Lu-Sheng Huang
Gang Ji
Hai-Dong Huang
Yun Xie
Geng-Ru Jiang
Xin Zhou
Wei Lu
Publication date
01-09-2018
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 9/2018
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-018-1919-5

Other articles of this Issue 9/2018

International Urology and Nephrology 9/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.